Tag
Anthem Biosciences Limited
3 articles
Anthem Q1 Revenue Down 23% YoY
Anthem Biosciences reported Q1FY27 unaudited consolidated revenue of ₹4,182 Mn, a 22.6% YoY decline.
EBITDA stood at ₹1,755 Mn with margins of 39.6%, while PAT was ₹1,199 Mn, up 11.7% YoY.
Management
Anthem Biosciences Q1 Revenue Down 22.6% YoY
Anthem Biosciences reported Q1FY27 unaudited consolidated financial results with revenue of ₹4,182 Mn, down 22.6% YoY.
EBITDA margin improved to 39.6%, a 153 bps YoY increase, while PAT was ₹1,199 Mn
Anthem Biosciences Q1 FY27 Net Profit Drops 19% YoY
• Anthem Biosciences reported Q1 FY27 standalone net profit of ₹1,020.09 million, a 31.2% decrease from the previous quarter.
• Consolidated revenue for the quarter stood at ₹4,431.06 million, with CR